Related Experiment Video
Updated: Mar 12, 2026

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage
Published on: August 21, 2021
SRSF10 Connects DNA Damage to the Alternative Splicing of Transcripts Encoding Apoptosis, Cell-Cycle Control, and DNA
Lulzim Shkreta1, Johanne Toutant1, Mathieu Durand2
1Département de Microbiologie et d'Infectiologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, QC J1E 4K8, Canada.
Abstract:
RNA binding proteins and signaling components control the production of pro-death and pro-survival splice variants of Bcl-x. DNA damage promoted by oxaliplatin increases the level of pro-apoptotic Bcl-xS in an ATM/CHK2-dependent manner, but how this shift is enforced is not known. Here, we show that in normally growing cells, when the 5' splice site of Bcl-xS is largely repressed, SRSF10 partially relieves repression and interacts with repressor hnRNP K and stimulatory hnRNP F/H proteins. Oxaliplatin abrogates the interaction of SRSF10 with hnRNP F/H and decreases the association of SRSF10 and hnRNP K with the Bcl-x pre-mRNA. Dephosphorylation of SRSF10 is linked with these changes. A broader analysis reveals that DNA damage co-opts SRSF10 to control splicing decisions in transcripts encoding components involved in DNA repair, cell-cycle control, and apoptosis. DNA damage therefore alters the interactions between splicing regulators to elicit a splicing response that determines cell fate.
Insights
DNA damage from oxaliplatin alters splicing regulation of Bcl-x by affecting RNA binding proteins like SRSF10. This shift favors the pro-apoptotic Bcl-xS variant, influencing cell fate decisions.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- RNA binding proteins regulate alternative splicing of Bcl-x, controlling pro-death (Bcl-xS) and pro-survival variants.
- DNA damage, induced by agents like oxaliplatin, increases pro-apoptotic Bcl-xS, but the underlying mechanism is unclear.
Purpose of the Study:
- To elucidate the mechanism by which DNA damage shifts Bcl-x splicing towards the pro-apoptotic variant.
- To investigate the role of splicing factor SRSF10 and its interactions with other proteins in response to DNA damage.
Main Methods:
- Investigated protein-RNA interactions using pre-mRNA from Bcl-x.
- Analyzed the effects of oxaliplatin on splicing factor binding and phosphorylation.
- Performed broader analysis of SRSF10 targets in response to DNA damage.
Main Results:
- Oxaliplatin treatment disrupts the interaction between SRSF10 and hnRNP F/H, and reduces SRSF10/hnRNP K binding to Bcl-x pre-mRNA.
- Dephosphorylation of SRSF10 correlates with these altered interactions.
- DNA damage redirects SRSF10 to regulate splicing of genes involved in DNA repair, cell cycle, and apoptosis.
Conclusions:
- DNA damage alters splicing factor interactions to promote the pro-apoptotic Bcl-xS variant, thereby influencing cell fate.
- SRSF10 plays a critical role in mediating the splicing response to DNA damage across multiple cellular pathways.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Nucleotide Excision Repair
RNA Splicing

